We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

281 hedge funds and large institutions have $2.32B invested in Amedisys in 2023 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 106 increasing their positions, 96 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

265% more call options, than puts

Call options by funds: $6.04M | Put options by funds: $1.65M

27% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 33

10% more repeat investments, than reductions

Existing positions increased: 106 | Existing positions reduced: 96

1% more funds holding

Funds holding: 277 → 281 (+4)

0.88% more ownership

Funds ownership: 95.72% → 96.6% (+0.88%)

10% less capital invested

Capital invested by funds: $2.56B → $2.32B (-$249M)

Holders
281
Holders Change
+4
Holders Change %
+1.44%
% of All Funds
4.48%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
42
Increased
106
Reduced
96
Closed
33
Calls
$6.04M
Puts
$1.65M
Net Calls
+$4.38M
Net Calls Change
+$4.86M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$30M
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$24.4M
3
Citadel Advisors
Citadel Advisors
Florida
+$20.6M
4
JP Morgan Chase
JP Morgan Chase
New York
+$20.5M
5
EP
Eversept Partners
New York
+$19.4M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$92.5M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$46.1M
3
Ameriprise
Ameriprise
Minnesota
-$23.4M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$17.6M
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$11.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Assenagon Asset Management
101
Assenagon Asset Management
Luxembourg
$1.86M -$4M -46,222 -65%
Manulife (Manufacturers Life Insurance)
102
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.85M -$97.9K -1,132 -4%
CS
103
Candriam SCA
Luxembourg
$1.73M +$108K +1,250 +5%
N
104
Numerai
California
$1.69M +$1.99M +22,991 New
Susquehanna International Group
105
Susquehanna International Group
Pennsylvania
$1.67M -$180K -2,076 -8%
YIH
106
Y-Intercept (HK)
Hong Kong
$1.65M +$1.52M +17,617 +361%
AB
107
Amalgamated Bank
New York
$1.64M -$420K -4,859 -18%
MIM
108
MetLife Investment Management
New Jersey
$1.46M -$46.1K -533 -3%
UBS Group
109
UBS Group
Switzerland
$1.41M +$147K +1,697 +10%
QT
110
Quantbot Technologies
New York
$1.39M +$803K +9,280 +97%
State of Tennessee, Department of Treasury
111
State of Tennessee, Department of Treasury
Tennessee
$1.35M +$1.58M +18,310 New
CAN
112
Cetera Advisor Networks
California
$1.24M -$3.46K -40 -0.2%
KI
113
Kula Investments
Illinois
$1.23M +$1.45M +16,768 New
JF
114
Jump Financial
Illinois
$1.23M -$827K -9,564 -36%
YCM
115
Yousif Capital Management
Michigan
$1.23M -$4.76K -55 -0.3%
AIP
116
Ameritas Investment Partners
Nebraska
$1.21M +$701K +8,100 +97%
Ohio Public Employees Retirement System (OPERS)
117
Ohio Public Employees Retirement System (OPERS)
Ohio
$1.2M -$38.2K -441 -3%
Canada Pension Plan Investment Board
118
Canada Pension Plan Investment Board
Ontario, Canada
$1.18M +$545K +6,300 +64%
BCM
119
Bayesian Capital Management
New York
$1.18M +$1.38M +16,000 New
CAM
120
Cresset Asset Management
Illinois
$1.16M +$3.55K +41 +0.3%
EAM
121
EFG Asset Management
Oregon
$1.13M +$492K +5,684 +59%
Nisa Investment Advisors
122
Nisa Investment Advisors
Missouri
$1.1M +$260 +3 +0%
JFG
123
Jefferies Financial Group
New York
$1.08M +$1.27M +14,639 New
COPPSERS
124
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.08M +$1.56K +18 +0.1%
Janus Henderson Group
125
Janus Henderson Group
United Kingdom
$1.06M -$592K -6,840 -32%
3 4
5
6 7

AMED Hedge Fund Activity: Q1 2023 in Review

281 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q1 2023, worth a combined $2.32B — down 9.7% from $2.56B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new AMED positions and 33 closed out — a net gain of 9 holders — while 106 added to existing stakes and 96 trimmed.

The largest buyer was Deerfield Management, adding an estimated $30M. The largest seller was BlackRock, cutting an estimated $92.5M.

  • 281 institutional investors held Amedisys (AMED) as of Q1 2023, up from 277 in Q4 2022.
  • Funds reported $2.32B of Amedisys stock for Q1 2023, down 9.7% quarter-over-quarter.
  • 42 funds opened new Amedisys positions in Q1 2023 and 33 closed out, a net change of +9 holders.
  • The largest Amedisys buyer in Q1 2023 was Deerfield Management, an estimated $30M added.
  • The largest Amedisys seller in Q1 2023 was BlackRock, an estimated $92.5M sold.

Based on aggregated 13F filings for Q1 2023.